Publication Name	World Journal of Transplantation
Manuscript ID	90382
Country	Egypt

Received	2023-12-01 18:32
Peer-Review Started	2023-12-01 18:32
To Make the First Decision
Return for Revision	2024-02-27 05:36
Revised	2024-02-29 21:30
Second Decision	2024-04-12 02:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-12 10:21
Articles in Press	2024-04-12 10:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-30 14:37
Publish the Manuscript Online	2024-06-14 08:01

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
Manuscript Source	Invited Manuscript
All Author List	Mai Hashem, Mohammed A Medhat, Doaa Abdeltawab and Nahed A Makhlouf
Funding Agency and Grant Number
Corresponding Author	Mai Hashem, MBChB, MD, MHSc, Lecturer, Department of Tropical Medicine and Gastroenterology, Assiut University Hospital, Assiut University Campus, Assiut 71515, Egypt, Assiut 71515, Egypt. maihashem@med.aun.edu.eg
Key Words	Donor pool; Hepatitis C-viremic organs; Non-viremic organs; Direct acting antivirals; Hepatitis C virus treated; Liver transplantation.
Core Tip	There is an imbalance between donor organ supply in liver transplantation and the demand. Unfulfilled demands in organ transplant communities prompt new approaches to increasing donor pools. Direct acting antiviral (DAA) regimens have proved higher efficacy in treating hepatitis C virus (HCV). Available data shows that HCV non-viremic donor organs can be used in HCV-negative or positive liver transplant candidates safely. Furthermore, using liver grafts from HCV-viremic donors in liver transplant candidates, even if they were HCV negative, is showing favorable outcomes. Preoperative informed consent and easy access to DAAs with the engagement of clinical pharmacists are indispensable to ensuring these good outcomes.
Publish Date	2024-06-14 08:01
Citation	<p>Hashem M, Medhat MA, Abdeltawab D, Makhlouf NA. Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time? <i>World J Transplant</i> 2024; 14(2): 90382</p>
URL	https://www.wjgnet.com/2220-3230/full/v14/i2/90382.htm
DOI	https://dx.doi.org/10.5500/wjt.v14.i2.90382

Full Article (PDF)	WJT-14-90382-with-cover.pdf
Manuscript File	90382_Auto_Edited-YJP.docx
Answering Reviewers	90382-answering-reviewers.pdf
Audio Core Tip	90382-audio.mp3
Conflict-of-Interest Disclosure Form	90382-conflict-of-interest-statement.pdf
Copyright License Agreement	90382-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	90382-non-native-speakers.pdf
Peer-review Report	90382-peer-reviews.pdf
Scientific Misconduct Check	90382-scientific-misconduct-check.png
Scientific Misconduct Check	90382-scientific-misconduct-check.png
Scientific Editor Work List	90382-scientific-editor-work-list.pdf
CrossCheck Report	90382-crosscheck-report.pdf